Epinephrine (l-adrenaline recalls
The FDA has published 2 recalls involving Epinephrine (l-adrenaline since 2023. The latest was reported on 1 Feb 2023. Most were for packaging defects. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2023
Last 12 months0reported
Class I2100% of total
Ongoing0latest 1 Feb 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 2 100%Class II 0 0%Class III 0 0%
Why epinephrine (l-adrenaline is recalled
Companies
By year
All epinephrine (l-adrenaline recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Epinephrine (L-Adrenaline), USP, CAS recalled | Spectrum Laboratory Products | Packaging Defects | Nationwide |
| Drug | CLASS I | Epinephrine (L-Adrenaline), USP, CAS 51-43-4 amber recalled | Spectrum Laboratory Products | Packaging Defects | Nationwide |
Should you stop taking Epinephrine (l-adrenaline?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.